FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118579908> ?p ?o ?g. }

• W3118579908 abstract "Abstract Background The optimal anticoagulant scheme during catheter-directed thrombolysis (CDT) for deep venous thrombosis (DVT) remains unknown. This study was performed to evaluate the feasibility of anticoagulation therapy using low molecular-weight heparin (LMWH) during CDT for DVT. Methods The clinical data of DVT patients who underwent CDT during the past six years was retrospectively collected and reviewed. Patients were divided into therapeutic-dose anticoagulation (TPDA) and sub therapeutic-dose anticoagulation (sub-TPDA) groups according to LMWH dosage. Results A total of 61 patients involving 61 limbs were comprised. Acute and subacute DVT were identified in 39 (63.9%) and 22 (36.1%) patients, respectively. Thrombosis involving the iliac vein was identified in 34 (55.7%) patients. Inferior vena cava filter placement was performed in 38 (62.3%) patients. Intraoperatively, adjunctive balloons, stents, and thrombectomy were provided for nine (14.8%), four (6.6%), and one (1.6%) patients, respectively. Twenty (32.8%) patients accepted TPDA therapy, while 41 (67.2%) patients were administrated with sub-TPDA therapy. Median urokinase infusion rate was 2.5 (0.83 to 5) × 10 4 U/h. Median infusion duration time was 4 (2 to 14) days, and median urokinase dose infused was 2.4 (0.6 to 10.80) × 10 6 U. During CDT, five (8.2%) cases of minor bleeding were observed, and blood transfusion was not required. No major bleeding, symptomatic pulmonary embolisms, or death occurred. Complete (> 90%) and partial thrombolysis (50 ~ 90%) were achieved in 56 (91.8%) patients. In comparison with sub-TPDA group, TPDA group exhibited no significant differences in baseline characteristics, clinical improvement, thrombolysis results, and complications. Conclusions Anticoagulation therapy using low molecular-weight heparin during CDT with low infusion rate for DVT is likely to be feasible and safe. Sub-therapeutic-dose anticoagulation and therapeutic-dose could be used for CDT with similar clinical outcome and bleeding complications." @default.
• W3118579908 created "2021-01-18" @default.
• W3118579908 creator A5042668842 @default.
• W3118579908 creator A5053061467 @default.
• W3118579908 creator A5072434771 @default.
• W3118579908 creator A5075318484 @default.
• W3118579908 creator A5079572598 @default.
• W3118579908 creator A5081782440 @default.
• W3118579908 creator A5087070308 @default.
• W3118579908 date "2021-01-28" @default.
• W3118579908 modified "2023-10-06" @default.
• W3118579908 title "Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis" @default.
• W3118579908 cites W1971018109 @default.
• W3118579908 cites W1985087116 @default.
• W3118579908 cites W2011124785 @default.
• W3118579908 cites W2029016555 @default.
• W3118579908 cites W2065458063 @default.
• W3118579908 cites W2103286082 @default.
• W3118579908 cites W2131099415 @default.
• W3118579908 cites W2159553511 @default.
• W3118579908 cites W2167955183 @default.
• W3118579908 cites W2217522721 @default.
• W3118579908 cites W2225937646 @default.
• W3118579908 cites W2323353687 @default.
• W3118579908 cites W2568898833 @default.
• W3118579908 cites W2587015734 @default.
• W3118579908 cites W2767064508 @default.
• W3118579908 cites W2774186378 @default.
• W3118579908 cites W2800452439 @default.
• W3118579908 cites W2887676988 @default.
• W3118579908 cites W3000017405 @default.
• W3118579908 cites W3013402355 @default.
• W3118579908 cites W3015573582 @default.
• W3118579908 cites W3033094629 @default.
• W3118579908 cites W4241608728 @default.
• W3118579908 doi "https://doi.org/10.1186/s12959-021-00260-3" @default.
• W3118579908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7845135" @default.
• W3118579908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33509199" @default.
• W3118579908 hasPublicationYear "2021" @default.
• W3118579908 type Work @default.
• W3118579908 sameAs 3118579908 @default.
• W3118579908 citedByCount "4" @default.
• W3118579908 countsByYear W31185799082022 @default.
• W3118579908 countsByYear W31185799082023 @default.
• W3118579908 crossrefType "journal-article" @default.
• W3118579908 hasAuthorship W3118579908A5042668842 @default.
• W3118579908 hasAuthorship W3118579908A5053061467 @default.
• W3118579908 hasAuthorship W3118579908A5072434771 @default.
• W3118579908 hasAuthorship W3118579908A5075318484 @default.
• W3118579908 hasAuthorship W3118579908A5079572598 @default.
• W3118579908 hasAuthorship W3118579908A5081782440 @default.
• W3118579908 hasAuthorship W3118579908A5087070308 @default.
• W3118579908 hasBestOaLocation W31185799081 @default.
• W3118579908 hasConcept C126322002 @default.
• W3118579908 hasConcept C141071460 @default.
• W3118579908 hasConcept C2776265017 @default.
• W3118579908 hasConcept C2776884760 @default.
• W3118579908 hasConcept C2776892390 @default.
• W3118579908 hasConcept C2777557582 @default.
• W3118579908 hasConcept C2778959117 @default.
• W3118579908 hasConcept C2779581417 @default.
• W3118579908 hasConcept C2780011451 @default.
• W3118579908 hasConcept C2780868729 @default.
• W3118579908 hasConcept C500558357 @default.
• W3118579908 hasConcept C71924100 @default.
• W3118579908 hasConceptScore W3118579908C126322002 @default.
• W3118579908 hasConceptScore W3118579908C141071460 @default.
• W3118579908 hasConceptScore W3118579908C2776265017 @default.
• W3118579908 hasConceptScore W3118579908C2776884760 @default.
• W3118579908 hasConceptScore W3118579908C2776892390 @default.
• W3118579908 hasConceptScore W3118579908C2777557582 @default.
• W3118579908 hasConceptScore W3118579908C2778959117 @default.
• W3118579908 hasConceptScore W3118579908C2779581417 @default.
• W3118579908 hasConceptScore W3118579908C2780011451 @default.
• W3118579908 hasConceptScore W3118579908C2780868729 @default.
• W3118579908 hasConceptScore W3118579908C500558357 @default.
• W3118579908 hasConceptScore W3118579908C71924100 @default.
• W3118579908 hasIssue "1" @default.
• W3118579908 hasLocation W31185799081 @default.
• W3118579908 hasLocation W31185799082 @default.
• W3118579908 hasLocation W31185799083 @default.
• W3118579908 hasLocation W31185799084 @default.
• W3118579908 hasLocation W31185799085 @default.
• W3118579908 hasOpenAccess W3118579908 @default.
• W3118579908 hasPrimaryLocation W31185799081 @default.
• W3118579908 hasRelatedWork W1990111999 @default.
• W3118579908 hasRelatedWork W2075890389 @default.
• W3118579908 hasRelatedWork W220073818 @default.
• W3118579908 hasRelatedWork W2352057135 @default.
• W3118579908 hasRelatedWork W2361322191 @default.
• W3118579908 hasRelatedWork W2368737360 @default.
• W3118579908 hasRelatedWork W2377960787 @default.
• W3118579908 hasRelatedWork W2407594508 @default.
• W3118579908 hasRelatedWork W2414818497 @default.
• W3118579908 hasRelatedWork W2432913978 @default.
• W3118579908 hasVolume "19" @default.
• W3118579908 isParatext "false" @default.
• W3118579908 isRetracted "false" @default.
• W3118579908 magId "3118579908" @default.
• W3118579908 workType "article" @default.